Skip to content

The Effects of a Positive Expiratory Pressure (PEP) on Dyspnea and Dynamic Hyperinflation During Exercise in Chronic Obstructive Pulmonary Disease (COPD) Patients

The Effects of a Positive Expiratory Pressure (PEP) on Dyspnea and Dynamic Hyperinflation During Exercise in COPD Patients

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00741832
Enrollment
11
Registered
2008-08-26
Start date
2008-03-31
Completion date
2009-02-28
Last updated
2008-11-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic Obstructive Pulmonary Disease

Keywords

chronic obstructive pulmonary disease, dynamic hyperinflation, dyspnea, recovery, positive expiratory pressure, exercise

Brief summary

From the relationship between pathophysiology of chronic obstructive pulmonary disease (COPD), dyspnea, and dynamic hyperinflation during ventilatory increasing, the investigators hypothesize that 1. Positive expiratory pressure (PEP) breathing will reduce dyspnea more than normal breathing during exercise in mild to moderate COPD patients. 2. PEP breathing will improve dynamic hyperinflation during exercise more than normal breathing in mild to moderate COPD patients. 3. PEP breathing will improve cardiorespiratory function during exercise than normal breathing in mild to moderate COPD patients.

Detailed description

Expiratory airflow limitation is the pathophysiological hallmark of chronic obstructive pulmonary disease (COPD) that leads to air trapping and increases in dynamic hyperinflation (DH) and consequently causes dyspnea during exercise. Although pursed lips breathing is a simple technique that provides a positive back pressure may retard the airway collapsed, but previous studies showed an unsuccessful reduction of DH which might cause by insufficient back pressure. And thereby a conical positive expiratory pressure (C-PEP) has been developed in our laboratory to generate back pressure higher than pursed lips breathing. Moreover, an effect of PEP on DH has not carried out in patient with COPD. Therefore, the objective of the present study was to examine effects of a C-PEP on DH and respiratory response during exercise in patient with COPD.

Interventions

DEVICEConical Positive Expiratory Pressure Device (C-PEP)

Conical positive expiratory pressure device (C-PEP) in this study was designed on the principle of expiratory flow retardation. The principle occurs when exhaling through a small tube diameter, i.e. a small straw, pursed lip breathing, or positive expiratory pressure. Expiratory retardation, results from a decrease in tube diameter, creates flow resistance during exhalation. With flow resistance, the greater the flow the greater the back pressure, and the less the flow the lower the pressure. Expiratory retardation was applied in an attempt to facilitate exhalation and to relieve the air trapping. The optimal design was found to be: cone shape, proximal diameter is 2.0 cm, distal diameter is 0.6 cm, and length is 2.5 cm. Subjects will rest for 10-15 minutes until HR, BP are stabilized. They will undertake 15 min of alternating quadriceps exercise (30% 1 RM) either breathing with the C-PEP device.

Subjects will rest for 10-15 minutes until HR, BP are stabilized. They will undertake 15 min of alternating quadriceps exercise (30% 1 RM) either breathing normally.

Sponsors

Khon Kaen University
Lead SponsorOTHER

Study design

Allocation
NON_RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
SUPPORTIVE_CARE
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
No minimum to 70 Years
Healthy volunteers
No

Inclusion criteria

* Patients with stable mild-to-moderate COPD (Both stages: FEV1/FVC \< 70%. Mild stage: FEV1 ≥ 80% predicted; Moderate stage: 50% ≤ FEV1 \< 80% predicted according to Global Initiative Obstructive Lung Disease (GOLD) guideline). * Free of exacerbations for more than 4 weeks (as defined by a change to pharmacological therapy, admission to hospital or ER or unscheduled clinic visit). * Good communication

Exclusion criteria

* Older than 70 years old * Musculoskeletal problems that limit mobility * Cardiovascular disease * Neurological or psychiatric illness * Patient on long term oxygen or domiciliary noninvasive positive pressure ventilation * Any other comorbidities which would affect ability to undertake exercise test

Design outcomes

Primary

MeasureTime frame
Inspiratory Capacityat 0th, 5th, ~20th minutes of exercises
Borg scaleat 0th and 20th minutes of exercises

Secondary

MeasureTime frame
PetCO2every minutes of exercise and recovery periods
Mouth pressureevery minutes of exercise periods
Flow rateevery minutes of exercise periods
Recovery timethe periods between end of symptomatic limited constance workload exercises to full recovery heart rate
Expiratory timeevery minutes of exercise and recovery periods
Heart Rateevery minutes of exercise and recovery periods
Exercise timeat the times when participants stop exercises
Inspiratory timeevery minutes of exercise and recovery periods
Respiratory rateevery minutes of exercise and recovery periods
Sp02every minutes of exercise and recovery periods

Countries

Thailand

Contacts

Primary ContactTadsawiya Padkao, Bachelor
mjz_tad@yahoo.com+6643202082
Backup ContactChulee Jones, Philosophy
chujones46@yahoo.co.uk+6643202399

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Apr 1, 2026